Deletion of fibroblast-derived CCN1 exacerbates renal fibrosis in mice
Abstract Chronic kidney disease is characterized by progressive renal fibrosis, yet effective anti-fibrotic therapies remain limited. Cellular Communication Network Factor 1 (CCN1) is a matricellular protein that regulates cell migration, proliferation, and extracellular matrix production. We previously demonstrated that proximal tubule-derived CCN1 promotes fibroblast recruitment and fibrosis during acute kidney injury; however, its role during progressive renal fibrosis remains unclear. Here, we investigated the cell source-specific functions of CCN1 using a unilateral ureteral obstruction (UUO) model and proximal tubule/fibroblast-specific CCN1-deficient mice. Proximal tubule-specific deletion of CCN1 did not alter renal fibrosis after UUO, whereas fibroblast-specific deletion unexpectedly exacerbated fibrosis and increased the expression of fibrotic markers. In vitro, CRISPR-Cas9-mediated CCN1 deletion in NRK49F fibroblasts markedly impaired cell migration and proliferation and increased cell size. RNA sequencing revealed downregulation of chemotaxis, PI3K-Akt, MAPK, focal adhesion, and TGF-β signaling pathways in CCN1 deleted NRK49F. Consistent with these findings, CCN1 deficiency reduced AKT and ERK phosphorylation and attenuated TGF-β-induced SMAD activation and expression of Acta2 and Ccn2 . In contrast, TGF-β-induced expression of extracellular matrix genes, including Col1a1 , and Fn1 , was enhanced by CCN1 deficiency, suggesting activation of alternative, SMAD-independent mechanisms. These findings indicate that fibroblast-derived CCN1 is not simply a pro-fibrotic factor but contributes to fibroblast integrity by maintaining their migratory and proliferative properties while modulating TGF-β signaling and extracellular matrix production. The biological effects of CCN1 are therefore highly dependent on its cellular source and the context of kidney injury.
Authors
- Satoaki Matoba (ORCID: https://orcid.org/0000-0002-9373-4331)
- Keiichi Tamagaki (ORCID: https://orcid.org/0000-0001-8589-5218)
- Ryo Kurose
- 奈都美 三島
- Yuhei Kirita (ORCID: https://orcid.org/0000-0002-5240-5531)
- NORIYUKI YAMASHITA (ORCID: https://orcid.org/0009-0002-6775-5777)
- Tetsuro Kusaba (ORCID: https://orcid.org/0000-0002-4698-2981)
- Atsushi Minamida
- Hisaya Tanaka
- Shinji Sawai
- Naoki Nakagawa (ORCID: https://orcid.org/0000-0002-5398-3667)
- Masashi Nakamura
- Minato Umehara (ORCID: https://orcid.org/0009-0004-5729-9418)
- Erika Tsujinaka-Sawai
- Tomohiro Nakata
- Satomi Yamamoto
Institutions
- Asahikawa Medical University (JP)
- Kyoto Prefectural University of Medicine (JP)
Publication Details
- Journal
- Research Square
- Published
- 2026-11-13
- DOI
- https://doi.org/10.21203/rs.3.rs-11442714/v1
- Primary Topic
- Connective Tissue Growth Factor Research
- Type
- preprint